David Polsky
Vice Chair for Research and the Alfred · NYU Grossman School of Medicine
Credentials: · · ·
History
- Present
Research · NYU Grossman School of Medicine
- 1994–1997
- 1993–1994
Preliminary or Transitional Year
1989–1993
Research
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
Nature · 2001 · 797 citations
Proceedings of the National Academy of Sciences of the United States of America · 2009 · 463 citations
Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria
Review · JAMA · 2004 · Last of 8 authors · 337 citations
- IO
32 papers
30 papers
29 papers
27 papers · 3 as a resident
27 papers
- AK
17 papers
16 papers
13 papers · 1 as a resident
Grants
- 2025–2029
National Cancer Institute · UH3
Contact PI · $387.7K · New York University School of Medicine
- 2025–2026
National Cancer Institute · UH2
Contact PI · $310.2K · New York University School of Medicine
- 2023–2026
TERT Epigenetic and Genomic Variants in Stage II Melanoma as Biomarkers of Outcome
National Cancer Institute · R21
Contact PI · $425.9K · New York University School of Medicine
- 2016–2022
Validation of Circulating Tumor DNA Assays for Detection of Metastatic Melanoma
National Cancer Institute · UH3
Contact PI · $1.4M · New York University School of Medicine
Clinical trials
- 2025–2026
A Community-based Educational Initiative to Raise Awareness of Melanoma and Other Skin Cancers.
Principal investigator · Active not recruiting
NYU Langone Health
- 2020–2023
Principal investigator · Completed
NYU Langone Health
- 2013–2016
Prospective Study of 2 mm Margins for the Biopsy of Dysplastic Nevi
Principal investigator · Completed
NYU Langone Health